Influence of Lenvatinib on the Functional Reprogramming of Peripheral Myeloid Cells in the Context of Non-Medullary Thyroid Carcinoma.
Pharmaceutics
View this publicationPharmaceutics
View this publicationJHEP reports : innovation in hepatology
View this publicationScientific reports
View this publicationMovement disorders : official journal of the Movement Disorder Society
View this publicationBMC infectious diseases
View this publicationEuropean urology
View this publicationInternational journal of molecular sciences
View this publicationMed (New York, N.Y.)
View this publicationBiology
View this publicationThe Journal of allergy and clinical immunology
View this publication